Arcline to Sell Medical Manufacturing Technologies to Perimeter Solutions for $685 Million

Arcline announced a definitive agreement to sell portfolio company Medical Manufacturing Technologies (MMT) to Perimeter Solutions (NYSE: PRM) for $685 million.

Rhea-AI Summary

Arcline announced a definitive agreement to sell portfolio company Medical Manufacturing Technologies (MMT) to Perimeter Solutions (NYSE: PRM) for $685 million. MMT is a Charlotte-based provider of automated medical device manufacturing with >350 employees, 14 production facilities, and service to more than 1,000 customers, including OEMs and CDMOs that make catheters, guidewires, stents, and related components.

The transaction follows Arcline's 2020 acquisition and 13 add-on deals that the firm says materially grew MMT's revenue and EBITDA. Closing is expected in Q1 2026, subject to regulatory approvals and customary closing conditions.

Positive

• $685 million definitive sale price to Perimeter
• MMT operates 14 production facilities
• MMT serves more than 1,000 customers globally
• Transaction expected to close in Q1 2026

Negative

• Closing is subject to regulatory approvals and customary conditions

Argus Dec 11 session

+0.24% close to close Open Argus

Details

News Market Reaction – PRM

In the Dec 11 session, PRM gained 0.24%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details PRM’s agreement to acquire MMT for $685 million in cash, extending its acq...

Analysis

This announcement details PRM’s agreement to acquire MMT for $685 million in cash, extending its acquisitive track record. MMT brings more than 1,000 customers, over 350 employees, and 14 facilities focused on complex medical device manufacturing. Recent SEC filings showed PRM balancing growth investments and buybacks while managing a $90.7 million quarterly net loss driven by non‑operational fees. Investors may watch regulatory approvals, closing progress into Q1 2026, and updated financing and leverage metrics following completion.

Key Figures

MMT purchase price: $685 million Customer count: More than 1,000 customers Employee count: Over 350 employees +4 more

MMT purchase price

$685 million

Cash consideration for acquisition by Perimeter Solutions

Customer count

More than 1,000 customers

Global medical device manufacturing customers served by MMT

Employee count

Over 350 employees

MMT workforce size

Production facilities

14 facilities

MMT global production footprint

Acquisitions completed

13 acquisitions

Targeted deals completed by Arcline to expand MMT

Acquisition timing

First quarter of 2026

Expected closing period for MMT transaction

Initial MMT acquisition year

2020

Year Arcline first acquired MMT

Historical Context

1 past event · Latest: Jul 28

1 event

1. Jul 28

   Earnings call timing

   24h Move

   -1.4%

   Announcement of date and time for Q2 2025 earnings release and call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

ebitda, oems, cdmos

3 terms

ebitda financial

"The firm significantly grew the company's revenue and EBITDA and completed 13 targeted acquisitions"

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.

View in glossary

oems technical

"including many of the world's leading medical technology OEMs and CDMOs"

OEMs, or Original Equipment Manufacturers, are companies that produce the main components or products that other companies use to build finished goods. For investors, OEMs are important because their performance can influence the supply chain, manufacturing costs, and overall market trends in industries like technology, automotive, and electronics. Their success often reflects broader economic health and consumer demand.

cdmos technical

"including many of the world's leading medical technology OEMs and CDMOs"

Contract Development and Manufacturing Organizations (CDMOs) are independent companies that help drug and biologic developers by designing, testing, scaling up and producing medicines on a contract basis — think of them as a hired factory and research partner that turns a medical idea into a manufacturable product. They matter to investors because they provide steady, service-based revenue, spread development and production risk for drug makers, and their capacity, quality and pricing can directly affect the speed and cost of getting medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASHVILLE, Tenn., Dec. 11, 2025 /PRNewswire/ -- Arcline Investment Management ("Arcline"), a growth-oriented private equity firm, today announced it has entered into a definitive agreement to sell its portfolio company Medical Manufacturing Technologies ("MMT"), to Perimeter Solutions, Inc (NYSE: PRM) ("Perimeter") for $685 million.

Based in Charlotte, North Carolina, MMT is a leading global provider of medical device manufacturing solutions, serving as a single-resource partner for automated, process-driven medical manufacturing. The company supports more than 1,000 customers — including many of the world's leading medical technology OEMs and CDMOs — in the production of complex interventional medical devices such as catheters, guidewires, stents, microcoils, and related components. With over 350 employees and 14 production facilities, MMT is a critical partner to customers operating in precision-dependent and highly regulated environments.

Since acquiring MMT in 2020, Arcline has executed a disciplined strategy to build a scaled provider of mission-critical manufacturing technologies for medical device OEMs and CDMOs. The firm significantly grew the company's revenue and EBITDA and completed 13 targeted acquisitions that broadened MMT's capabilities, including automation solutions and specialty manufacturing services that simplify and optimize complex production processes. Arcline thanks Chief Executive Officer Robbie Atkinson and the entire MMT team for their partnership. 

The transaction is expected to close in the first quarter of 2026, subject to regulatory approvals and customary closing conditions.

William Blair and Houlihan Lokey served as financial advisors, and Kirkland & Ellis LLP and Fredrikson & Byron P.A. served as legal advisors to Arcline in connection with the transaction.

About Arcline Investment Management
Arcline Investment Management is a growth-oriented private equity firm with over $20 billion in assets under management. Arcline seeks to build the next generation of Industrial Compounders – market-leading, non-disruptible industrial platforms designed to consistently grow earnings over decades. For more information visit www.arcline.com.

Contact Information:
contact@arcline.com
www.arcline.com

Contact (For Press Inquiries Only):

Tim Ragones / Alexander Wolfson
Joele Frank, Wilkinson Brimmer Katcher
Arcline-JF@joelefrank.com
(212) 355-4449

View original content:https://www.prnewswire.com/news-releases/arcline-to-sell-medical-manufacturing-technologies-to-perimeter-solutions-for-685-million-302638695.html

SOURCE Arcline Investment Management

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is Perimeter Solutions paying for MMT (PRM transaction)?

Perimeter Solutions agreed to buy MMT for $685 million under a definitive agreement.

When is the Perimeter (PRM) acquisition of MMT expected to close?

The transaction is expected to close in Q1 2026, subject to regulatory approvals and customary closing conditions.

What does MMT bring to Perimeter (PRM) in terms of scale and customers?

MMT has >350 employees, 14 production facilities, and serves more than 1,000 customers, including medical device OEMs and CDMOs.

Did Arcline grow MMT before the sale to Perimeter (PRM)?

Arcline acquired MMT in 2020 and completed 13 targeted acquisitions, reporting growth in the company's revenue and EBITDA.

Are there regulatory hurdles for Perimeter's (PRM) purchase of MMT?

Yes. The deal closing is explicitly subject to regulatory approvals and customary closing conditions.